Ibrutinib or Idelalisib Selecting Appropriate Therapy for Relapsed CLL - 101931

Spotlight
Video

Ibrutinib or Idelalisib Selecting Appropriate Therapy for Relapsed CLL

ASHReport has 317 videos Subscribe Here

Loading........
Description: Jeff Sharman, MD Medical Director of Hematology Research for US Oncology discusses Ibrutinib or Idelalisib Selecting Appropriate Therapy for Relapsed CLL
Shared By : ASHReport
Posted on : 12/10/15
Added : 3 years ago